$SYK
AI 分析生成于 May 18, 2026
AI Score
Buy$SYK
Stryker Corporation
$SYKNYSEHealthcareLarge-Cap
Stryker operates as a medical technology company offering orthopedic implants, surgical equipment, and neurotechnology products worldwide.
Market Cap
$145B
Revenue (TTM)
$22.5B
+10.5%
Net Income (TTM)
$4.2B
+14.5%
EPS (TTM)
$11.25
P/E Ratio
34.2
Dividend Yield
0.9%
52-Week Range
$325-$415
Beta
0.92
Dimension Scores
Fundamental
80Technical
72Sentiment
76Risk / Reward
76Momentum
72Financial Health
Profitability
80strong
Growth
78moderate
Liquidity
78moderate
Solvency
75moderate
Efficiency
78moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $SYK
Free · No credit card required
免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。